Author

B. Grubor-Bauk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Abayasingam· 1 shared A. Adhikari· 1 shared A. Bain· 1 shared A. Henders· 1 shared A. R. Lloyd· 1 shared A. W. Bartlett· 1 shared A. Wuethrich· 1 shared B. Hudson· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Abayasingam

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cardiovascular symptoms of PASC are associated with trace-level cytokines that affect the function of human pluripotent stem cell derived cardiomyocytes

J. Sinclair, C. Vedelago, F. Ryan, M. Carney, M. Redd, M. Lynn, B. Grubor-Bauk, Y. Cao, A. Henders, K. Y. Chew, D. Gilroy, K. Greaves, L. Labzin, L. Ziser, K. Ronacher, , K. Short

This study identifies trace-level cytokines in PASC patients linked to cardiovascular symptoms and shows their impact on cardiomyocyte function using nanotechnology detection.

bioRxiv · Apr 11, 2024 · PreprintMicrobiology

Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection.

A. Adhikari, A. Abayasingam, C. Rodrigo, D. Agapiou, E. Pandzic, N. A. Brasher, B. S. M. Fernando, E. Keoshkerian, H. Li, H. N. Kim, M. Lord, G. Popovic, W. Rawlinson, M. Mina, J. J. Post, , N. Tedla

This study shows that phagocytic and neutralisation functions of anti-Spike antibodies persist in SARS-CoV-2 convalescents despite declining antibody titers, with improved antibody affinity correlating with maintained effector functions.

bioRxiv · Dec 21, 2021 · PreprintImmunology